Focus: Achieve Life Sciences is a public-stage biotech company headquartered in Seattle focusing on small molecule therapeutics in oncology and smoking cessation. The company operates a lean, clinical-stage pipeline with multiple Phase 2 and Phase 3 programs.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Achieve Life Sciences to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Achieve Life Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Achieve Life Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
+2 more
+2 more
+2 more
+2 more
Achieve Life Sciences Secures Up to $354 Million Private Placement to Advance Cytisinicline for Smoking and Vaping Cessation - Minichart
Achieve Life Sciences Secures Up to $354 Million Private Placement to Advance Cytisinicline for Smoking and Vaping Cessation Minichart
$354M funding and new CEO reshape Achieve Life Sciences (NASDAQ: ACHV) - Stock Titan
$354M funding and new CEO reshape Achieve Life Sciences (NASDAQ: ACHV) Stock Titan
Achieve Life Sciences names new CEO, adds board members - Investing.com
Achieve Life Sciences names new CEO, adds board members Investing.com
Achieve Life Sciences Appoints New Healthcare Leaders to Board and Secures Up to $354 Million Financing for Cytisinicline Development - Moomoo
Achieve Life Sciences Appoints New Healthcare Leaders to Board and Secures Up to $354 Million Financing for Cytisinicline Development Moomoo
Achieve Life Sciences Secures $354 Million Financing to Advance Cytisinicline Development for Nicotine Dependence - Quiver Quantitative
Achieve Life Sciences Secures $354 Million Financing to Advance Cytisinicline Development for Nicotine Dependence Quiver Quantitative
Achieve secures $180M now, with $174M more tied to FDA approval - Stock Titan
Achieve secures $180M now, with $174M more tied to FDA approval Stock Titan
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo